Cargando…
Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis
Chronic inflammation and proteinuria is a risk factor for cardiovascular disease (CVD) in patients with chronic kidney diseases and rheumatologic disorders. Our aim was to investigate the CVD events (CVDEs) and survival between the patients with FMF-related AA amyloidosis and glomerulonephropathies...
Autores principales: | Romano, Micol, Piskin, David, Berard, Roberta A., Jackson, Bradley C., Acikel, Cengizhan, Carrero, Juan J., Lachmann, Helen J., Yilmaz, Mahmut I., Demirkaya, Erkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591897/ https://www.ncbi.nlm.nih.gov/pubmed/33110219 http://dx.doi.org/10.1038/s41598-020-75433-7 |
Ejemplares similares
-
Evaluation of E148Q and Concomitant AA Amyloidosis in Patients with Familial Mediterranean Fever
por: Arici, Zehra Serap, et al.
Publicado: (2021) -
Assessment of Surrogate Markers for Cardiovascular Disease in Familial Mediterranean Fever-Related Amyloidosis Patients Homozygous for M694V Mutation in MEFV Gene
por: Sahin, Sezgin, et al.
Publicado: (2022) -
Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever
por: Piskin, David, et al.
Publicado: (2022) -
Clinical and demographic characteristics of children with familial mediterranean fever in Central Anatolia
por: Akin, Onur, et al.
Publicado: (2011) -
Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study
por: Romano, Micol, et al.
Publicado: (2022)